» Articles » PMID: 37510306

The Effect of Hormonal Therapy on the Behavioral Outcomes in 47,XXY (Klinefelter Syndrome) Between 7 and 12 Years of Age

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Jul 29
PMID 37510306
Authors
Affiliations
Soon will be listed here.
Abstract

47,XXY, also known as Klinefelter syndrome, is the most commonly occurring sex chromosomal aneuploidy (SCA). Hormonal replacement therapy (HRT) has been associated with improved neurodevelopmental capabilities in boys with 47,XXY, although studies investigating HRT's possible positive effect on behavioral outcomes are scarce. This study explores the association between behavioral outcomes and HRT in boys ages 7-12. Patients were divided into 4 groups based on HRT status: untreated, early hormonal treatment (EHT), hormonal booster therapy (HBT), and both EHT and HBT. Analysis of Variance (ANOVA) and Kruskal-Wallis tests were conducted to determine group differences on the Child Behavior Checklist (CBCL) and the Behavior Rating Inventory of Executive Function (BRIEF). The treated groups were found to have better scores in emotional control, initiative, organization of materials, behavioral rating index, metacognition index, and global executive composite than the untreated group on the BRIEF. On the CBCL, the treated groups presented better scores for somatic complaints, social problems, thought problems, attention problems, aggressive behavior, internalizing problems, total problems, affective problems, somatic problems, ADHD problems, oppositional defiant problems, and sluggish problems in comparison to the untreated group. These results offer evidence that HRT, specifically the combination of both EHT and HBT, may be successful in mitigating some undesirable behavioral outcomes. Further research is necessary to determine the efficacy of the combination of EHT and HBT regarding dosage, specific ages, and long-term benefits.

Citing Articles

Testosterone Effects on Short-Term Physical, Hormonal, and Neurodevelopmental Outcomes in Infants with 47,XXY/Klinefelter Syndrome: The TESTO Randomized Controlled Trial.

Davis S, Howell S, Janusz J, Lahlou N, Reynolds R, Thompson T medRxiv. 2024; .

PMID: 39711709 PMC: 11661422. DOI: 10.1101/2024.12.09.24318726.

References
1.
Samango-Sprouse C, Brooks M, Counts D, Hamzik M, Song S, Powell S . A longitudinal perspective of hormone replacement therapies (HRTs) on neuromotor capabilities in males with 47,XXY (Klinefelter syndrome). Genet Med. 2022; 24(6):1274-1282. DOI: 10.1016/j.gim.2022.03.004. View

2.
Samango-Sprouse C, Stapleton E, Lawson P, Mitchell F, Sadeghin T, Powell S . Positive effects of early androgen therapy on the behavioral phenotype of boys with 47,XXY. Am J Med Genet C Semin Med Genet. 2015; 169(2):150-7. DOI: 10.1002/ajmg.c.31437. View

3.
Raznahan A, Lee N, Greenstein D, Wallace G, Blumenthal J, Clasen L . Globally Divergent but Locally Convergent X- and Y-Chromosome Influences on Cortical Development. Cereb Cortex. 2014; 26(1):70-9. PMC: 4701121. DOI: 10.1093/cercor/bhu174. View

4.
Gil M, Accurti V, Santacruz B, Plana M, Nicolaides K . Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017; 50(3):302-314. DOI: 10.1002/uog.17484. View

5.
van Rijn S, Swaab H, Aleman A, Kahn R . Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J Autism Dev Disord. 2008; 38(9):1634-41. DOI: 10.1007/s10803-008-0542-1. View